查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2035253

睡眠健康市場預測至2034年－按產品類型、睡眠障礙類型、最終用戶、通路和地區分類的全球分析

Sleep Health Market Forecasts to 2034 - Global Analysis By Product Type, Sleep Disorder Type, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球睡眠健康市場規模將達到 921 億美元，並在預測期內以 8.7% 的複合年成長率成長，到 2034 年將達到 1,796 億美元。

睡眠健康涵蓋一系列產品、服務和治療方法，旨在診斷、管理和改善睡眠質量，並解決睡眠相關障礙。該市場包括藥物干預、治療設備（例如持續性正壓呼吸器）、穿戴式睡眠追蹤設備、數位療法和專業的睡眠醫療保健服務。睡眠障礙盛行率的上升、人們對睡眠不足對健康影響的認知不斷提高，以及遠端患者監護解決方案的日益普及，正將睡眠健康從一個細分醫學領域轉變為主流健康和醫療保健的重點領域。

壓力相關睡眠障礙盛行率增加

現代生活方式的特徵是工作壓力大、過度使用電子設備以及經濟不確定性，這些因素導致全球失眠和其他壓力引起的睡眠障礙病例急劇增加。臨床研究一致表明，慢性壓力與晝夜節律紊亂和睡眠品質差密切相關，因此尋求專業介入的患者群體日益壯大。世界衛生組織（WHO）已將睡眠不足列為已開發國家和開發中國家的公共衛生流行病。睡眠不足盛行率的上升直接推動了對診斷服務、藥物和行為療法的需求，同時，雇主和醫療保健系統也越來越認知到睡眠健康是整體健康和生產力的關鍵因素。

診斷和治療方案高成本

對於許多患者而言，例如居住在醫療保險覆蓋不足地區的患者，先進的診斷程序（如睡眠多項生理檢查）和治療設備（如自適應伺服通氣系統）仍然價格昂貴，難以負擔。雖然家用睡眠監測設備價格相對低廉，但對於低收入者來說，仍然是一筆不小的開銷。耗材、設備維護和專家會診等持續費用進一步加重了家庭預算的負擔。這種經濟負擔造成了醫療服務取得的巨大不平等，限制了市場成長潛力，並導致許多原本可以透過適當醫療干預有效控制的疾病患者未能得到診斷或治療。

數位療法和遠端醫療的擴展

遠端監測技術和基於應用程式的失眠認知行為療法正在透過提高醫療服務的可近性和降低成本，徹底改變醫療保健的模式。這些數位化解決方案使患者能夠在家中舒適地接受實證治療，消除了地理限制，並減少了患者親自前往專科醫生診療的需求。與消費者穿戴式裝置和智慧家居設備的整合，可提供持續的數據流，從而提高診斷準確性並實現個人化治療。隨著臨床證據的不斷積累，醫療保健計劃和保險公司正在擴大對數位化睡眠療法的報銷範圍，這為技術主導的睡眠健康服務供應商和平台創造了巨大的成長機會。

過度依賴未經監管的消費級睡眠設備

市面上睡眠追蹤器和健康設備的快速普及對醫學檢驗的診斷方法構成了威脅。這些消費級設備往往缺乏臨床檢驗，可能為使用者提供誤導或令人焦慮的睡眠評分和建議。依賴未經監管產品的個人可能會延誤對睡眠呼吸中止症和嗜睡症等嚴重的專業醫療評估。不同設備和平台的數據品質差異使得與電子健康記錄 (EHR) 的整合變得複雜，這給希望將患者生成的數據納入臨床決策，同時又要確保診斷準確性和患者安全的醫療服務提供者帶來了挑戰。

新冠疫情的影響：

新冠疫情對睡眠健康市場造成了根本性的衝擊，同時也提高了人們對睡眠在免疫功能中作用的認知。大範圍的封鎖、遠距辦公的興起以及與病毒相關的焦慮情緒導致全球失眠症患者激增，這種失眠症被稱為“新冠失眠症”，患者群體急劇擴大。遠端醫療的快速普及使得即使面對面諮詢受到限制，睡眠諮詢和持續性正壓呼吸器（CPAP）的遠距監測也能持續進行。然而，睡眠檢查室運作的中斷導致診斷延遲，許多未確診的睡眠呼吸中止症患者因此耽誤了治療。疫情永久地將醫療服務模式轉變為混合模式，將線上諮詢與居家檢測和治療支援相結合。

在預測期內，失眠症細分市場預計將佔據最大的市場佔有率。

預計在預測期內，失眠領域將佔據最大的市場佔有率。這主要是由於失眠症在所有年齡層和人群中普遍存在。全球約有三分之一的成年人在一生中的某個階段會受到失眠症的影響，其中近10%的人患有慢性失眠。失眠症與精神疾病、慢性疼痛和生活方式因素密切相關，導致人們對藥物治療、認知行為療法和數位治療方法的需求持續成長。處方安眠藥的接受度不斷提高以及非藥物治療的保險覆蓋範圍不斷擴大，進一步鞏固了失眠症在整個睡眠健康市場中的主導地位。

在預測期內，「商業和機構項目」細分市場預計將呈現最高的複合年成長率。

在預測期內，「企業和機構專案」細分市場預計將呈現最高的成長率，這反映出雇主越來越意識到睡眠健康對員工生產力和安全的影響。具有前瞻性的企業正在將睡眠教育、篩檢和干涉措施融入全面的企業健康計劃中，提供內部睡眠評估、治療設備補貼以及數位化睡眠指導平台的使用權限。同樣，運動表現中心也在應用先進的睡眠監測技術來最佳化運動員的恢復和表現。越來越多的證據表明，改善睡眠可以降低缺勤率、減少職場並增強認知功能，這進一步強化了這一趨勢，並推動了各行各業對員工睡眠健康計畫的投資。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其高昂的醫療保健支出、廣泛的睡眠診斷醫療覆蓋範圍以及消費者對睡眠健康的高度重視。該地區成熟的睡眠醫療保健基礎設施包括數千家認證睡眠中心和大量註冊睡眠專家。肥胖是阻塞型睡眠呼吸中止症中止症的主要風險因素，其在美國和加拿大的盛行率仍然很高，這支撐了對持續性正壓呼吸器（CPAP）設備及相關耗材的需求。總部位於該地區的領先製藥和醫療設備製造商將繼續投資於睡眠健康創新，進一步鞏固北美在預測期內的主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於快速的都市化、可支配收入的成長以及人們對睡眠障礙作為可治療疾病的認知不斷提高。儘管中國、印度和東南亞的許多人面臨著因高壓工作環境和不斷變化的數位化生活方式而導致的壓力相關睡眠問題，但其診斷和治療服務的普及率仍然低於西方市場。不斷擴大的醫療基礎設施、政府為意識提升而採取的舉措以及國際醫療設備製造商的進入，正在加速市場發展。鑑於該地區龐大的人口基數和老齡化人口結構，以及家庭睡眠監測和遠端醫療的日益普及，亞太地區預計將成為成長最快的地區。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球睡眠健康市場：依產品類型分類

  • 睡眠監測和診斷設備
    • 睡眠多導圖（PSG）設備
    • 家用睡眠監測設備
    • 活動記錄儀
  • 治療性睡眠設備
    • CPAP設備
    • 雙水平氣道正壓通氣設備
    • 自適應伺服通氣（ASV）
    • 氧氣療法設備
    • 神經刺激裝置
  • 消費者睡眠解決方案
    • 穿戴式睡眠追蹤器
    • 智慧寢具解決方案
  • 睡眠健康軟體和數位解決方案
    • 睡眠追蹤應用程式
    • 睡眠分析平台
    • 數位療法
  • 睡眠補充劑和藥物
    • 非處方（OTC）助眠藥
    • 處方安眠藥
    • 天然草本補充劑
  • 睡眠服務
    • 睡眠診所和檢測機構
    • 診斷和檢測服務
    • 行為治療（CBT-I）
    • 遠端醫療睡眠服務

第6章：全球睡眠健康市場：依睡眠障礙類型分類

  • 失眠
  • 睡眠呼吸中止症
  • 不寧腿（RLS）
  • 嗜睡症
  • 晝夜節律紊亂
  • 其他睡眠障礙

第7章：全球睡眠健康市場：依最終用戶分類

  • 醫療服務提供方
    • 醫院
    • 睡眠診所和診斷中心
  • 居家照護環境
  • 個人消費者
  • 企業和機構的項目
    • 企業健康計劃
    • 運動表現中心

第8章：全球睡眠健康市場：依通路分類

  • 線上管道
    • 電子商務平台
    • 直接面對消費者 (D2C)
  • 離線頻道
    • 醫療機構
    • 零售藥房
    • 專業商店和批發商

第9章 全球睡眠健康市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • ResMed
  • Philips
  • Fisher & Paykel Healthcare
  • SomnoMed
  • Sleep Number Corporation
  • Tempur Sealy International
  • Serta Simmons Bedding
  • Casper Sleep
  • Eight Sleep
  • Withings
  • Fitbit
  • Oura Health
  • Lofta
  • Dreem
  • Nox Medical
Product Code: SMRC35663

According to Stratistics MRC, the Global Sleep Health Market is accounted for $92.1 billion in 2026 and is expected to reach $179.6 billion by 2034 growing at a CAGR of 8.7% during the forecast period. Sleep health encompasses a broad range of products, services, and treatments aimed at diagnosing, managing, and improving sleep quality and addressing sleep-related disorders. This market includes pharmaceutical interventions, therapeutic devices such as CPAP machines, sleep tracking wearables, digital therapeutics, and professional sleep medicine services. Rising prevalence of sleep disorders, increasing awareness of the health consequences of poor sleep, and growing adoption of remote patient monitoring solutions are collectively transforming sleep health from a niche medical field into a mainstream wellness and healthcare priority.

Market Dynamics:

Driver:

Rising prevalence of stress-related sleep disorders

Modern lifestyles characterized by high work pressure, digital device overuse, and economic uncertainty have contributed to a dramatic increase in insomnia and other stress-induced sleep conditions globally. Clinical studies consistently link chronic stress with disrupted circadian rhythms and reduced sleep quality, creating a growing patient population seeking professional intervention. The World Health Organization has identified insufficient sleep as a public health epidemic across developed and developing nations. This expanding prevalence directly fuels demand for diagnostic services, pharmaceutical treatments, and behavioral therapies, while employers and healthcare systems increasingly recognize sleep health as a critical component of overall well-being and productivity.

Restraint:

High cost of diagnostic and treatment solutions

Advanced diagnostic procedures such as in-lab polysomnography and treatment devices like adaptive servo-ventilation systems remain prohibitively expensive for many patients, particularly in regions with inadequate health insurance coverage. Home sleep testing devices, while more affordable, still present financial barriers for lower-income populations. Ongoing expenses for consumables, equipment maintenance, and specialist consultations further strain household budgets. This cost burden creates significant disparities in access to sleep healthcare, limiting market growth potential and leaving many individuals with undiagnosed or undertreated conditions that could otherwise be managed effectively with appropriate medical intervention.

Opportunity:

Expansion of digital therapeutics and telemedicine

Remote monitoring technologies and app-based cognitive behavioral therapy for insomnia are revolutionizing sleep healthcare delivery by improving accessibility and reducing costs. These digital solutions enable patients to receive evidence-based treatment from home, eliminating geographical barriers and reducing the need for in-person specialist visits. Integration with consumer wearables and smart home devices provides continuous data streams that enhance diagnostic accuracy and treatment personalization. Healthcare systems and insurers increasingly reimburse digital sleep therapeutics as clinical evidence of their effectiveness accumulates, creating substantial growth opportunities for technology-driven sleep health providers and platforms.

Threat:

Overreliance on unregulated consumer sleep devices

Rapid proliferation of commercially available sleep trackers and wellness gadgets poses a threat to medically validated diagnostic approaches. These consumer devices often lack clinical validation, yet provide users with sleep scores and recommendations that may be misleading or anxiety-inducing. Individuals relying on unregulated products may delay seeking professional medical evaluation for serious conditions such as sleep apnea or narcolepsy. Inconsistent data quality across devices and platforms complicates integration with electronic health records, creating challenges for healthcare providers attempting to incorporate patient-generated data into clinical decision-making while maintaining diagnostic accuracy and patient safety standards.

Covid-19 Impact:

The COVID-19 pandemic fundamentally disrupted sleep health markets while simultaneously elevating awareness of sleep's role in immune function. Widespread lockdowns, remote work transitions, and virus-related anxiety triggered a global surge in insomnia, termed "coronasomnia," dramatically expanding the addressable patient population. Telemedicine adoption accelerated rapidly, enabling continuity of sleep consultations and remote CPAP monitoring when in-person visits were restricted. However, disruptions to sleep lab operations caused diagnostic backlogs, delaying care for many patients with undiagnosed sleep apnea. The pandemic permanently shifted care delivery toward hybrid models combining virtual consultations with home-based testing and therapeutic support.

The Insomnia segment is expected to be the largest during the forecast period

The Insomnia segment is expected to account for the largest market share during the forecast period, driven by the pervasive nature of this sleep disorder across all age groups and demographics. Insomnia affects approximately one-third of the global adult population at some point in their lives, with chronic insomnia persisting in nearly ten percent of individuals. The condition's strong association with mental health disorders, chronic pain, and lifestyle factors generates sustained demand for pharmaceutical interventions, cognitive behavioral therapy, and digital therapeutics. Growing acceptance of prescription sleep aids and expanding insurance coverage for non-pharmacological treatments further solidifies insomnia's dominant position across the sleep health market.

The Corporate & Institutional Programs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Corporate & Institutional Programs segment is predicted to witness the highest growth rate, reflecting rising employer recognition of sleep health's impact on workforce productivity and safety. Forward-thinking organizations are integrating sleep education, screening, and intervention into comprehensive corporate wellness initiatives, offering on-site sleep assessments, reimbursements for therapy devices, and access to digital sleep coaching platforms. Sports performance centers are similarly adopting advanced sleep monitoring to optimize athlete recovery and competitive outcomes. This trend is amplified by mounting evidence linking improved sleep with reduced absenteeism, fewer workplace accidents, and enhanced cognitive performance, incentivizing investment in employee sleep health programs across diverse industries.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high healthcare expenditure, widespread health insurance coverage for sleep diagnostics, and strong consumer awareness of sleep health. The region's mature sleep medicine infrastructure includes thousands of accredited sleep centers and a large workforce of board-certified sleep specialists. Prevalence of obesity, a major risk factor for obstructive sleep apnea, remains elevated throughout the United States and Canada, sustaining demand for CPAP devices and related supplies. Major pharmaceutical and medical device companies headquartered in the region continuously invest in sleep health innovation, reinforcing North America's leadership position throughout the forecast timeline.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by rapid urbanization, rising disposable incomes, and growing recognition of sleep disorders as treatable medical conditions. Large populations in China, India, and Southeast Asia face increasing stress-related sleep issues linked to demanding work cultures and digital lifestyle changes, yet penetration of diagnostic and treatment services remains low compared to Western markets. Expanding healthcare infrastructure, government initiatives promoting sleep health awareness, and entry of international device manufacturers are accelerating market development. The region's large and aging population base, combined with growing adoption of home sleep testing and telemedicine, positions Asia Pacific for the fastest growth trajectory.

Key players in the market

Some of the key players in Sleep Health Market include ResMed, Philips, Fisher & Paykel Healthcare, SomnoMed, Sleep Number Corporation, Tempur Sealy International, Serta Simmons Bedding, Casper Sleep, Eight Sleep, Withings, Fitbit, Oura Health, Lofta, Dreem, and Nox Medical.

Key Developments:

In April 2026, Fisher & Paykel Healthcare expanded its digital ecosystem by launching streamlined "Rapid CPAP Setups" and enhanced remote monitoring tools designed to prevent hospital readmissions through real-time therapy adjustments for sleep apnea patients.

In March 2026, ResMed published its sixth annual Global Sleep Survey, revealing that while global wearable use for sleep tracking surged from 16% to 53% in one year, nearly half of women and 42% of men still report significant difficulty falling asleep due to rising stress and anxiety.

In January 2026, Lofta announced a strategic alliance with Accomplish Health to integrate medical weight loss programs into its direct-to-consumer sleep apnea care platform, targeting the high comorbidity rate between obesity and sleep-disordered breathing.

Product Types Covered:

  • Sleep Monitoring & Diagnostic Devices
  • Therapeutic Sleep Devices
  • Consumer Sleep Solutions
  • Sleep Health Software & Digital Solutions
  • Sleep Supplements & Medications
  • Sleep Services

Sleep Disorder Types Covered:

  • Insomnia
  • Sleep Apnea
  • Restless Leg Syndrome (RLS)
  • Narcolepsy
  • Circadian Rhythm Disorders
  • Other Sleep Disorders

End Users Covered:

  • Healthcare Providers
  • Homecare Settings
  • Individual Consumers
  • Corporate & Institutional Programs

Distribution Channels Covered:

  • Online Channels
  • Offline Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Sleep Health Market, By Product Type

  • 5.1 Sleep Monitoring & Diagnostic Devices
    • 5.1.1 Polysomnography (PSG) Devices
    • 5.1.2 Home Sleep Testing Devices
    • 5.1.3 Actigraphy Devices
  • 5.2 Therapeutic Sleep Devices
    • 5.2.1 CPAP Devices
    • 5.2.2 BiPAP Devices
    • 5.2.3 Adaptive Servo-Ventilation (ASV)
    • 5.2.4 Oxygen Therapy Devices
    • 5.2.5 Neurostimulation Devices
  • 5.3 Consumer Sleep Solutions
    • 5.3.1 Wearable Sleep Trackers
    • 5.3.2 Smart Bedding Solutions
  • 5.4 Sleep Health Software & Digital Solutions
    • 5.4.1 Sleep Tracking Applications
    • 5.4.2 Sleep Analysis Platforms
    • 5.4.3 Digital Therapeutics
  • 5.5 Sleep Supplements & Medications
    • 5.5.1 Over-the-Counter (OTC) Sleep Aids
    • 5.5.2 Prescription Sleep Medications
    • 5.5.3 Natural & Herbal Supplements
  • 5.6 Sleep Services
    • 5.6.1 Sleep Clinics & Labs
    • 5.6.2 Diagnostic & Testing Services
    • 5.6.3 Behavioral Therapy (CBT-I)
    • 5.6.4 Telehealth Sleep Services

6 Global Sleep Health Market, By Sleep Disorder Type

  • 6.1 Insomnia
  • 6.2 Sleep Apnea
  • 6.3 Restless Leg Syndrome (RLS)
  • 6.4 Narcolepsy
  • 6.5 Circadian Rhythm Disorders
  • 6.6 Other Sleep Disorders

7 Global Sleep Health Market, By End User

  • 7.1 Healthcare Providers
    • 7.1.1 Hospitals
    • 7.1.2 Sleep Clinics & Diagnostic Centers
  • 7.2 Homecare Settings
  • 7.3 Individual Consumers
  • 7.4 Corporate & Institutional Programs
    • 7.4.1 Corporate Wellness Programs
    • 7.4.2 Sports & Performance Centers

8 Global Sleep Health Market, By Distribution Channel

  • 8.1 Online Channels
    • 8.1.1 E-commerce Platforms
    • 8.1.2 Direct-to-Consumer (D2C)
  • 8.2 Offline Channels
    • 8.2.1 Healthcare Facilities
    • 8.2.2 Retail Pharmacies
    • 8.2.3 Specialty Stores & Distributors

9 Global Sleep Health Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 ResMed
  • 12.2 Philips
  • 12.3 Fisher & Paykel Healthcare
  • 12.4 SomnoMed
  • 12.5 Sleep Number Corporation
  • 12.6 Tempur Sealy International
  • 12.7 Serta Simmons Bedding
  • 12.8 Casper Sleep
  • 12.9 Eight Sleep
  • 12.10 Withings
  • 12.11 Fitbit
  • 12.12 Oura Health
  • 12.13 Lofta
  • 12.14 Dreem
  • 12.15 Nox Medical

List of Tables

  • Table 1 Global Sleep Health Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Sleep Health Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Sleep Health Market Outlook, By Sleep Monitoring & Diagnostic Devices (2023-2034) ($MN)
  • Table 4 Global Sleep Health Market Outlook, By Polysomnography (PSG) Devices (2023-2034) ($MN)
  • Table 5 Global Sleep Health Market Outlook, By Home Sleep Testing Devices (2023-2034) ($MN)
  • Table 6 Global Sleep Health Market Outlook, By Actigraphy Devices (2023-2034) ($MN)
  • Table 7 Global Sleep Health Market Outlook, By Therapeutic Sleep Devices (2023-2034) ($MN)
  • Table 8 Global Sleep Health Market Outlook, By CPAP Devices (2023-2034) ($MN)
  • Table 9 Global Sleep Health Market Outlook, By BiPAP Devices (2023-2034) ($MN)
  • Table 10 Global Sleep Health Market Outlook, By Adaptive Servo-Ventilation (ASV) (2023-2034) ($MN)
  • Table 11 Global Sleep Health Market Outlook, By Oxygen Therapy Devices (2023-2034) ($MN)
  • Table 12 Global Sleep Health Market Outlook, By Neurostimulation Devices (2023-2034) ($MN)
  • Table 13 Global Sleep Health Market Outlook, By Consumer Sleep Solutions (2023-2034) ($MN)
  • Table 14 Global Sleep Health Market Outlook, By Wearable Sleep Trackers (2023-2034) ($MN)
  • Table 15 Global Sleep Health Market Outlook, By Smart Bedding Solutions (2023-2034) ($MN)
  • Table 16 Global Sleep Health Market Outlook, By Sleep Health Software & Digital Solutions (2023-2034) ($MN)
  • Table 17 Global Sleep Health Market Outlook, By Sleep Tracking Applications (2023-2034) ($MN)
  • Table 18 Global Sleep Health Market Outlook, By Sleep Analysis Platforms (2023-2034) ($MN)
  • Table 19 Global Sleep Health Market Outlook, By Digital Therapeutics (2023-2034) ($MN)
  • Table 20 Global Sleep Health Market Outlook, By Sleep Supplements & Medications (2023-2034) ($MN)
  • Table 21 Global Sleep Health Market Outlook, By Over-the-Counter (OTC) Sleep Aids (2023-2034) ($MN)
  • Table 22 Global Sleep Health Market Outlook, By Prescription Sleep Medications (2023-2034) ($MN)
  • Table 23 Global Sleep Health Market Outlook, By Natural & Herbal Supplements (2023-2034) ($MN)
  • Table 24 Global Sleep Health Market Outlook, By Sleep Services (2023-2034) ($MN)
  • Table 25 Global Sleep Health Market Outlook, By Sleep Clinics & Labs (2023-2034) ($MN)
  • Table 26 Global Sleep Health Market Outlook, By Diagnostic & Testing Services (2023-2034) ($MN)
  • Table 27 Global Sleep Health Market Outlook, By Behavioral Therapy (CBT-I) (2023-2034) ($MN)
  • Table 28 Global Sleep Health Market Outlook, By Telehealth Sleep Services (2023-2034) ($MN)
  • Table 29 Global Sleep Health Market Outlook, By Sleep Disorder Type (2023-2034) ($MN)
  • Table 30 Global Sleep Health Market Outlook, By Insomnia (2023-2034) ($MN)
  • Table 31 Global Sleep Health Market Outlook, By Sleep Apnea (2023-2034) ($MN)
  • Table 32 Global Sleep Health Market Outlook, By Restless Leg Syndrome (RLS) (2023-2034) ($MN)
  • Table 33 Global Sleep Health Market Outlook, By Narcolepsy (2023-2034) ($MN)
  • Table 34 Global Sleep Health Market Outlook, By Circadian Rhythm Disorders (2023-2034) ($MN)
  • Table 35 Global Sleep Health Market Outlook, By Other Sleep Disorders (2023-2034) ($MN)
  • Table 36 Global Sleep Health Market Outlook, By End User (2023-2034) ($MN)
  • Table 37 Global Sleep Health Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 38 Global Sleep Health Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 39 Global Sleep Health Market Outlook, By Sleep Clinics & Diagnostic Centers (2023-2034) ($MN)
  • Table 40 Global Sleep Health Market Outlook, By Homecare Settings (2023-2034) ($MN)
  • Table 41 Global Sleep Health Market Outlook, By Individual Consumers (2023-2034) ($MN)
  • Table 42 Global Sleep Health Market Outlook, By Corporate & Institutional Programs (2023-2034) ($MN)
  • Table 43 Global Sleep Health Market Outlook, By Corporate Wellness Programs (2023-2034) ($MN)
  • Table 44 Global Sleep Health Market Outlook, By Sports & Performance Centers (2023-2034) ($MN)
  • Table 45 Global Sleep Health Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 46 Global Sleep Health Market Outlook, By Online Channels (2023-2034) ($MN)
  • Table 47 Global Sleep Health Market Outlook, By E-commerce Platforms (2023-2034) ($MN)
  • Table 48 Global Sleep Health Market Outlook, By Direct-to-Consumer (D2C) (2023-2034) ($MN)
  • Table 49 Global Sleep Health Market Outlook, By Offline Channels (2023-2034) ($MN)
  • Table 50 Global Sleep Health Market Outlook, By Healthcare Facilities (2023-2034) ($MN)
  • Table 51 Global Sleep Health Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 52 Global Sleep Health Market Outlook, By Specialty Stores & Distributors (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.